After three days of brief respite, the Covid cases and deaths have shown a gradual increase once again. India on Thursday reported 48,786 new Covid-19
Tag: dcgi
Cipla gets DCGI nod to import Moderna’s Covid vaccine for restricted emergency use in India: Sources
India’s drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna’s COVID-19 vaccine for restricted emergency use in the country, official sources said on Tuesday.
Biophore seeks DCGI emergency use approval of Aviptadil for Covid-19
New Delhi: Biophore India Pharmaceuticals on Friday announced that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the treatment of moderate to severe
Serum Institute gets DCGI’s nod to manufacture Covid jab Sputnik V in India
New Delhi: The DCGI has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik Covid-19 vaccine in India for examination, test and analysis with certain conditions, official
DCGI waives norms for clearing foreign-made jabs to bolster availability
India’s apex drug regulator has waived the requirement of testing every batch of foreign-made Covid-19 vaccines by the Central Drugs Laboratory, Kasauli and post-launch bridging
Zydus gets EUA for single-dose ‘Virafin’ to treat moderate Covid infection
Zydus Cadila on Friday announced that it has received restricted emergency use approval from the Indian drug regulator, Drug Controller General of India (DCGI), for
Panel Allows Bharat Biotech To Give 3rd Dose Of Covaxin In Trial: Report
New Delhi: The expert panel of India’s drug regulator DCGI has allowed Bharat Biotech to give a third dose of Covaxin to a few volunteers
